Genmab — November 2018
-
Zacks Equity Research?? https://finance.yahoo.com/news/genmab-gnmsf-earnings-expected-grow-153003579.html
-
DDB om aktierne efter midvejdvalget. https://danskebank.dk/privat/news/investeringsnyt/forside---investeringsnyt/chefstrateg---saadan-kan-trumps-valglussing-ramme-dine-aktier
-
Hans-Henrik om Midtvejsvalget: http://www.proinvestor.com/debat/76466
-
Trump i en nøddeskal https://twitter.com/aljwhite/status/1060224698561318913?s=21
-
Vi har arbejdet sammen før. Nu fik vi muligheden igen.
-
God morgen.

-
NEJM : Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation https://www.nejm.org/doi/full/10.1056/NEJMoa1807438
-
New trial: Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction (IDA53) https://clinicaltrials.gov/ct2/show/NCT03734198
-
God morgen

-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind